 | • レポートコード：MRC2102QY16880 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の23価肺炎球菌多糖体ワクチン市場について種類別（単回投与バイアル、プレフィルドシリンジ）、用途別（子供用（2～10）、成人用（10～64）、高齢者用（≥65））、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・23価肺炎球菌多糖体ワクチン市場の概要 ・世界の主要地域別23価肺炎球菌多糖体ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の23価肺炎球菌多糖体ワクチン市場規模2015-2026：種類別（単回投与バイアル、プレフィルドシリンジ） ・世界の23価肺炎球菌多糖体ワクチン市場規模2015-2026：用途別（子供用（2～10）、成人用（10～64）、高齢者用（≥65）） ・23価肺炎球菌多糖体ワクチンの米国市場規模2015-2020 ・23価肺炎球菌多糖体ワクチンのヨーロッパ市場規模2015-2020 ・23価肺炎球菌多糖体ワクチンの中国市場規模2015-2020 ・23価肺炎球菌多糖体ワクチンの日本市場規模2015-2020 ・23価肺炎球菌多糖体ワクチンの東南アジア市場規模2015-2020 ・23価肺炎球菌多糖体ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・23価肺炎球菌多糖体ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・23価肺炎球菌多糖体ワクチンの市場動向・機会・課題 ・調査の結論 |
23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria.
23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.
North America is the largest supplier and consumption market of 23-Valent Pneumococcal Polysaccharide Vaccine, with a production market share nearly 70% and sales market share nearly 28% in 2015. Because Sanofipasteur, a competitor from Europe, transferred its vaccine type gradually, the production market share of North America in the world has enjoyed a dramatic increase.
Market Analysis and Insights: Global 23-Valent Pneumococcal Polysaccharide Vaccine Market
The global 23-Valent Pneumococcal Polysaccharide Vaccine market size is projected to reach US$ 5330.9 million by 2026, from US$ 2378.2 million in 2020, at a CAGR of 14.4% during 2021-2026.
Global 23-Valent Pneumococcal Polysaccharide Vaccine Scope and Market Size
The global 23-Valent Pneumococcal Polysaccharide Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global 23-Valent Pneumococcal Polysaccharide Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the 23-Valent Pneumococcal Polysaccharide Vaccine market is segmented into
Single Dose Vial
Pre-filled Syringe
Segment by Application, the 23-Valent Pneumococcal Polysaccharide Vaccine market is segmented into
For Children (2-10)
For Person (10-64)
For The Old (≥65)
The 23-Valent Pneumococcal Polysaccharide Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the 23-Valent Pneumococcal Polysaccharide Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Analysis
23-Valent Pneumococcal Polysaccharide Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in 23-Valent Pneumococcal Polysaccharide Vaccine business, the date to enter into the 23-Valent Pneumococcal Polysaccharide Vaccine market, 23-Valent Pneumococcal Polysaccharide Vaccine product introduction, recent developments, etc.
The major vendors covered:
MSD
Sanofipasteur
CDIBP
1 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview
1.1 23-Valent Pneumococcal Polysaccharide Vaccine Product Scope
1.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
1.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2020-2026)
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
1.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Comparison by Application (2020-2026)
1.3.2 For Children (2-10)
1.3.3 For Person (10-64)
1.3.4 For The Old (≥65)
1.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Trends (2015-2026)
2 23-Valent Pneumococcal Polysaccharide Vaccine Estimate and Forecast by Region
2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Estimates and Projections (2015-2026)
2.4.3 China 23-Valent Pneumococcal Polysaccharide Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Estimates and Projections (2015-2026)
2.4.6 India 23-Valent Pneumococcal Polysaccharide Vaccine Estimates and Projections (2015-2026)
3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Competition Landscape by Players
3.1 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Players by Sales (2015-2020)
3.2 Global Top 23-Valent Pneumococcal Polysaccharide Vaccine Players by Revenue (2015-2020)
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine as of 2019)
3.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key 23-Valent Pneumococcal Polysaccharide Vaccine Players (Opinion Leaders)
4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2015-2020)
4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Type (2021-2026)
5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2015-2020)
5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast by Application (2021-2026)
6 United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures
6.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2015-2020)
6.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2015-2020)
6.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2015-2020)
7 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures
7.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2015-2020)
7.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2015-2020)
7.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2015-2020)
8 China 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures
8.1 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2015-2020)
8.2 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2015-2020)
8.3 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2015-2020)
9 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures
9.1 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (3015-3030)
9.2 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2015-2020)
9.3 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2015-2020)
10 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures
10.1 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2015-2020)
10.2 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2015-2020)
10.3 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2015-2020)
11 India 23-Valent Pneumococcal Polysaccharide Vaccine Market Facts & Figures
11.1 India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2015-2020)
11.2 India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2015-2020)
11.3 India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in 23-Valent Pneumococcal Polysaccharide Vaccine Business
12.1 MSD
12.1.1 MSD Corporation Information
12.1.2 MSD Business Overview
12.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
12.1.5 MSD Recent Development
12.2 Sanofipasteur
12.2.1 Sanofipasteur Corporation Information
12.2.2 Sanofipasteur Business Overview
12.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
12.2.5 Sanofipasteur Recent Development
12.3 CDIBP
12.3.1 CDIBP Corporation Information
12.3.2 CDIBP Business Overview
12.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
12.3.5 CDIBP Recent Development
…
13 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Cost Analysis
13.1 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
13.4 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
14.3 23-Valent Pneumococcal Polysaccharide Vaccine Customers
15 Market Dynamics
15.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Trends
15.2 23-Valent Pneumococcal Polysaccharide Vaccine Opportunities and Drivers
15.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
15.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Region (2015-2020)
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2015-2020)
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Region (2015-2020)
Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) Forecast by Region (2021-2026)
Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share Forecast by Region (2021-2026)
Table 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine (K Dose) of Key Companies (2015-2020)
Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Company (2015-2020)
Table 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Company (2015-2020)
Table 16. Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine as of 2019)
Table 17. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (USD/Dose) of Key Company (2015-2020)
Table 18. Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key 23-Valent Pneumococcal Polysaccharide Vaccine Players
Table 22. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Type (2015-2020)
Table 23. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2015-2020)
Table 24. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (K Dose) by Type (2015-2020)
Table 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2021-2026)
Table 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2021-2026)
Table 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (K Dose) by Type (2021-2026)
Table 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Application (2015-2020)
Table 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Application (2015-2020)
Table 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (K Dose) by Application (2015-2020)
Table 34. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Application (2021-2026)
Table 35. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Application (2021-2026)
Table 36. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2021-2026)
Table 38. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (K Dose) by Application (2021-2026)
Table 39. United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Company (2015-2020)
Table 40. United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2015-2020)
Table 41. United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Type (2015-2020)
Table 42. United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2015-2020)
Table 43. United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Application (2015-2020)
Table 44. United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2015-2020)
Table 45. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Company (2015-2020)
Table 46. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2015-2020)
Table 47. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Type (2015-2020)
Table 48. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2015-2020)
Table 49. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Application (2015-2020)
Table 50. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2015-2020)
Table 51. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Company (2015-2020)
Table 52. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2015-2020)
Table 53. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Type (2015-2020)
Table 54. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2015-2020)
Table 55. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Application (2015-2020)
Table 56. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2015-2020)
Table 57. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Company (2015-2020)
Table 58. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2015-2020)
Table 59. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Type (2015-2020)
Table 60. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2015-2020)
Table 61. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Application (2015-2020)
Table 62. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Company (2015-2020)
Table 64. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Type (2015-2020)
Table 66. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Type (2015-2020)
Table 68. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2015-2020)
Table 69. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Company (2015-2020)
Table 70. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company (2015-2020)
Table 71. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Type (2015-2020)
Table 72. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2015-2020)
Table 73. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) by Application (2015-2020)
Table 74. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2015-2020)
Table 75. MSD Corporation Information
Table 76. MSD Description and Business Overview
Table 77. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 79. MSD Recent Development
Table 80. Sanofipasteur Corporation Information
Table 81. Sanofipasteur Description and Business Overview
Table 82. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 84. Sanofipasteur Recent Development
Table 85. CDIBP Corporation Information
Table 86. CDIBP Description and Business Overview
Table 87. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product
Table 89. CDIBP Recent Development
Table 90. Production Base and Market Concentration Rate of Raw Material
Table 91. Key Suppliers of Raw Materials
Table 92. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List
Table 93. 23-Valent Pneumococcal Polysaccharide Vaccine Customers List
Table 94. 23-Valent Pneumococcal Polysaccharide Vaccine Market Key Trends
Table 95. 23-Valent Pneumococcal Polysaccharide Vaccine Key Opportunities and Drivers
Table 96. 23-Valent Pneumococcal Polysaccharide Vaccine Market Challenges
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. 23-Valent Pneumococcal Polysaccharide Vaccine Product Picture
Figure 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Application in 2020 & 2026
Figure 6. For Children (2-10) Examples
Figure 7. For Person (10-64) Examples
Figure 8. For The Old (≥65) Examples
Figure 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) Growth Rate (2015-2026)
Figure 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose) Growth Rate (2015-2026)
Figure 16. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest 23-Valent Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue in 23-Valent Pneumococcal Polysaccharide Vaccine 2015 & 2019
Figure 27. 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2015-2020)
Figure 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Application (2015-2020)
Figure 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2019
Figure 33. United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2019
Figure 34. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company in 2019
Figure 35. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2019
Figure 36. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2019
Figure 37. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company in 2019
Figure 38. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2019
Figure 39. China 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2019
Figure 40. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company in 2019
Figure 41. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2019
Figure 42. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2019
Figure 43. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company in 2019
Figure 44. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2019
Figure 45. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2019
Figure 46. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Company in 2019
Figure 47. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2019
Figure 48. India 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 51. Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 52. 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
ワクチン用コンジュゲートの世界市場レポート2020 Market Analysis and Insights: Global Vaccine Conjugate Market The global Vaccine Conjugate market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Vaccine Conjugate Scope and Market Size The global Vaccine Conjugate market is s…- ヒト用ワクチンの世界市場レポート2020 A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. China …
- 麻疹（はしか）ワクチンの世界市場レポート2020 Measles vaccine is made by inoculation of attenuated strain of measles virus into chicken embryo cells, culture and harvesting of virus venom, and then freeze-drying. Injection into the lateral deltoid muscle attachment of the upper arm can prevent measles. Market Analysis and Insights: Global Measl…
- 点鼻ワクチンの世界市場レポート2020 Nasal Spray Vaccine refers to a vaccine injected through the nose, which is mostly used for influenza. The FluMist is the only alternative to the flu shot without a needle and is given in the form of a nasal spray. Nasal Spray Vaccine is widely sales for Child and Adult The most proportion of Nasal …
- インフルエンザワクチンの世界市場レポート2020 Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 6…